Evidence map›Paper›PMID 27718171›Full record

ReviewCurrent diabetes reports2016

Update on Clinical Utility of Continuous Glucose Monitoring in Type 1 Diabetes.

Nalani Haviland, John Walsh, Ruth Roberts, Timothy S Bailey

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nalani HavilandAdvanced Metabolic Care and Research, 625 W. Citracado Pkwy, Ste 108, Escondido, CA, 92025, USA.
John WalshAdvanced Metabolic Care and Research, 625 W. Citracado Pkwy, Ste 108, Escondido, CA, 92025, USA.
Ruth RobertsDiabetes Services, Inc., 1030 West Upas St., San Diego, CA, 92103, USA.
Timothy S BaileyAMCR Institute, 625 West Citracado Parkway Suite 112, Escondido, CA, 92025, USA. tbailey@amcrinstitute.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the early 2000s, continuous glucose monitoring (CGM) technology has advanced to become a standard of care in the treatment of type 1 diabetes. Unfortunately, CGM use is not commonly integrated into practice. This article will review the history, technology, and need for systematic training in CGM. Additionally, it will review recent clinical trial data demonstrating the benefits that CGM offers to all people with type 1 diabetes and the clinicians who care for them.

Indexed as

Blood GlucoseBlood Glucose Self-MonitoringDiabetes Mellitus, Type 1Glycated HemoglobinHumansBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanArtificial pancreasCGMContinuous glucose monitoringInsulin therapyType 1 diabetes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.